RxDoctor Payments Data

Joyce Stevens, MD

Family Medicine · Flint, MINPI 1346332400

Payments from drug & device makers

$17,863in general payments, 2019–2025

Across 994 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • GSK$2K
  • Amgen$1K
  • Pfizer$1K
  • Lilly USA, LLC$1K
  • AstraZeneca$1K
  • plus $9K from 48 others

What the payments were for

  • Food & beverage$17,802100%
  • Education$610%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)180$2,386
GSK79$2,145
Amgen72$1,353
Pfizer81$1,232
Lilly USA, LLC80$1,069
AstraZeneca44$1,027
Novo Nordisk51$963
Otsuka America Pharmaceutical, Inc.34$822
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)62$778
Biohaven Pharmaceuticals, Inc.14$649
Bayer47$631
Teva Pharmaceuticals USA, Inc.21$397
Johnson & Johnson15$387
Boehringer Ingelheim17$374
Takeda Pharmaceuticals U.S.A., Inc.19$328
Novartis15$325
Vanda Pharmaceuticals Inc.23$315
Axsome Therapeutics, Inc.14$295
Lundbeck LLC12$262
Alkermes, Inc.9$228
Paratek Pharmaceuticals, Inc.14$227
Biohaven Pharmaceutical Holding Company Ltd.11$224
Neurocrine Biosciences, Inc.10$197
Sunovion Pharmaceuticals Inc.4$137
Mylan Specialty L.p.7$118
Exact Sciences6$102
Nestle Healthcare Nutrition Inc.6$98
Idorsia Pharmaceuticals US Inc5$85
Abbott4$63
Sanofi-aventis U.S. LLC3$58
Corcept Therapeutics2$53
Astellas Pharma US Inc3$49
UCB, Inc.2$46
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$42
Aimmune Therapeutics, Inc.2$41
Supernus Pharmaceuticals, Inc.2$33
Shield Therapeutics Inc2$32
Currax Pharmaceuticals LLC2$26
GRT US Holding, Inc.2$26
Otsuka Pharmaceutical Development & Commercialization, Inc.1$24
Optinose US, Inc.1$21
Actelion Pharmaceuticals US, Inc.1$21
Phathom Pharmaceuticals, Inc.1$19
Merck1$17
Ultragenyx Pharmaceutical Inc.1$16
Seqirus USA Inc1$15
Hologic Sales And Service, LLC1$15
Dexcom, Inc.1$15
Inari Medical, Inc.1$14
Collegium Pharmaceutical, Inc.1$14
Amarin Pharma, Inc.1$13
Shire North American Group Inc1$12
Zyla Life Sciences, Inc.1$12
Orthogenrx Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,863 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$31,625
Medicare patients
111
Services billed
332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide34$45,909
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$42,091
JardianceEmpagliflozin26$23,541
EntrestoSacubitril/Valsartan21$22,909
EliquisApixaban19$22,594
MounjaroTirzepatide12$21,174
FarxigaDapagliflozin Propanediol21$19,031
RybelsusSemaglutide11$15,559
VraylarCariprazine Hcl11$14,892
TrulicityDulaglutide14$14,889
TradjentaLinagliptin16$14,266
JanuviaSitagliptin Phosphate23$12,014
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$11,523
Xtampza ErOxycodone Myristate11$10,270
SymbicortBudesonide/Formoterol Fumarate23$7,705

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$963$61,46845 claims
GSKTrelegy Ellipta, Anoro Ellipta$2,145$48,81974 claims
Boehringer IngelheimJardiance, Tradjenta, Pradaxa$374$39,78853 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,027$38,25856 claims
Lilly USA, LLCMounjaro, Trulicity$1,069$36,06226 claims
NovartisEntresto$325$22,90921 claims
PfizerEliquis$1,232$22,59419 claims
AbbVieVraylar$2,386$14,89211 claims
MerckJanuvia$17$12,01423 claims
Collegium Pharmaceutical, Inc.Xtampza Er$14$10,27011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Flint

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →